These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2575677)

  • 1. [Serum diagnosis of cancer with monoclonal antibodies].
    Kannagi R
    Rinsho Byori; 1989 Jul; (Spec No 82):52-86. PubMed ID: 2575677
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancarcinoma T and Tn epitopes: autoimmunogens and diagnostic markers that reveal incipient carcinomas and help establish prognosis.
    Springer GF; Desai PR; Wise W; Carlstedt SC; Tegtmeyer H; Stein R; Scanlon EF
    Immunol Ser; 1990; 53():587-612. PubMed ID: 1713069
    [No Abstract]   [Full Text] [Related]  

  • 3. Advantage of cocktail-use of two anti-tumor monoclonal antibodies, KM-93 and KM-231, in serum diagnosis of cancer.
    Shitara K; Hanai N; Furuya A; Yoshida H
    Anticancer Res; 1989; 9(4):999-1004. PubMed ID: 2479331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antigens associated with cancer of the pancreas].
    Burtin P
    Bull Cancer; 1990; 77(1):69-73. PubMed ID: 2317577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of blood group antigen in sera as a tumor marker].
    Imai K; Arimura Y; Yachi A
    Nihon Rinsho; 1990 Feb; 48 Suppl():912-6. PubMed ID: 1972427
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pancreatic cancer and tumor markers].
    Watanabe H; Kawakami H; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Sawabu N
    Rinsho Byori; 1991 Jun; Suppl 89():58-72. PubMed ID: 1680205
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor markers in pancreatic cancer--current concepts.
    Schmiegel W
    Hepatogastroenterology; 1989 Dec; 36(6):446-9. PubMed ID: 2693300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardization and quality control of tumour marker assays.
    Ward AM
    Dis Markers; 1991; 9(3-4):127-32. PubMed ID: 1813205
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic diagnosis of cancer--tumor markers].
    Kawai T
    Gan No Rinsho; 1989 Jan; Spec No():13-8. PubMed ID: 2915470
    [No Abstract]   [Full Text] [Related]  

  • 10. [Application of mouse monoclonal antibody to the diagnosis of cancer].
    Takahashi T; Ueda R
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2015-22. PubMed ID: 2424372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.
    Scambia G; Panici PB; Baiocchi G; Perrone L; Iacobelli S; Mancuso S
    Anticancer Res; 1988; 8(4):761-4. PubMed ID: 3178164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of present tumor markers].
    Ohkura H
    Gan To Kagaku Ryoho; 1993 May; 20(7):843-9. PubMed ID: 7683865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha1,2fucosylation is a superior predictor of postoperative prognosis for colorectal cancer compared with blood group A, B, or sialyl Lewis X antigen generated within colorectal tumor tissues.
    Tsuboi K; Asao T; Ide M; Hashimoto S; Noguchi K; Kominato Y; Saniabadi AR; Kuwano H; Yazawa S
    Ann Surg Oncol; 2007 Jun; 14(6):1880-9. PubMed ID: 17375356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for 2----6 sialyl Lewis a antigen--2. Evaluation of clinical significance].
    Imura H; Takahashi T; Matsuda T; Yoshida O; Ohkura H; Seitetsu Y; Seino Y; Ishii M; Kuwabara M; Ariyoshi Y
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2203-12. PubMed ID: 2660749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment of colorectal cancer using monoclonal antibodies].
    Inagi H; Okuda H; Shimano T; Kadota T; Mori T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2291-7. PubMed ID: 3460528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucinic tumor markers recognized by monoclonal antibodies.
    Seregni E; Bombardieri E; Maffioli L; Buraggi GL
    J Nucl Med Allied Sci; 1990; 34(4):314-20. PubMed ID: 2090797
    [No Abstract]   [Full Text] [Related]  

  • 18. [Usefulness of tumor markers in the diagnosis of squamous carcinoma of the esophagus].
    Pecchio F; Albertino B; Ferrarotti G; Baldi S; Adamo R; Lo Faso C; Oliaro A; Dei Poli M; Rapellino M
    Minerva Chir; 1988 Sep; 43(18):1469-71. PubMed ID: 3226583
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
    Wu JT
    Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biochemistry and clinical evaluation of cancer-associated carbohydrate antigens: an approach to the diagnosis using monoclonal antibody cocktails].
    Kannagi R
    Rinsho Byori; 1986 Nov; 34(11):1247-64. PubMed ID: 3820695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.